The Price Is Right (But Buyer Beware)

Affiliations

¹ Department of Internal Medicine, Division of Cardiovascular Medicine, University of Texas Health Sciences Center-Houston, Houston, Texas. Electronic address: Salman.A.Arain@uth.tmc.edu.
² Department of Medicine, The Ochsner Clinical School, University of Queensland, New Orleans, Louisiana.

Free article

Editorial

Salman A Arain et al. JACC Cardiovasc Interv. 2016.

Free article

. 2016 Nov 28;9(22):2353-2355.

doi: 10.1016/j.jcin.2016.10.001.

¹ Department of Internal Medicine, Division of Cardiovascular Medicine, University of Texas Health Sciences Center-Houston, Houston, Texas. Electronic address: Salman.A.Arain@uth.tmc.edu.
² Department of Medicine, The Ochsner Clinical School, University of Queensland, New Orleans, Louisiana.

No abstract available

Keywords: cost-effectiveness; drug-coated balloons; percutaneous transluminal balloon angioplasty; peripheral arterial disease.

Comment on

Cost-Effectiveness of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons Versus Standard Percutaneous Transluminal Angioplasty: Results From the IN.PACT SFA II Trial.
Salisbury AC, Li H, Vilain KR, Jaff MR, Schneider PA, Laird JR, Cohen DJ. Salisbury AC, et al. JACC Cardiovasc Interv. 2016 Nov 28;9(22):2343-2352. doi: 10.1016/j.jcin.2016.08.036. JACC Cardiovasc Interv. 2016. PMID: 27884360 Clinical Trial.